NVDA Unusual Options Activity - 2026-03-09 📊

Quick Take 🎯

Hey traders! NVDA just blew up our unusual options scanner in a way that demands attention. Three massive LEAP call purchases totaling $80 MILLION in premium hit the tape within a 25-minute window -- all January 2027 expiration, all bought ABOVE the ask, all classified as new positions. The biggest single trade carried a z-score of 115.97, meaning its volume was roughly 115x the historical average for that contract. With GTC 2026 just 7 days away, someone with very deep pockets is making a giant bet that NVDA is heading significantly higher over the next 10 months.

---

Company Overview 🏢

NVIDIA Corporation (NVDA)

• Market Cap: $4.32 Trillion
• Sector: Semiconductors & Related Devices
• Current Price: ~$179.42
• 52-Week Range: $86.62 - $212.19
• FY2026 Revenue: $215.9 billion, up 65% YoY
• Forward P/E: ~22-30x (below its 10-year average of 53.67x)

NVIDIA is the dominant force in AI computing. The company holds roughly 80% of the AI data center chip market, with Data Center revenue accounting for 91%+ of total sales. Beyond GPUs, NVIDIA has built a full-stack ecosystem -- CUDA software, networking (ConnectX, Spectrum-X), DPUs, and now co-packaged optics -- that creates deep customer lock-in. They just posted Q4 FY2026 revenue of $68.1 billion (up 73% YoY) and guided Q1 FY2027 to $78 billion, crushing consensus by $5 billion.

---

Today's Unusual Options Activity 🔥

The Big Money Moves

Three trades hit the tape between 10:55 and 11:20 AM -- all January 2027 LEAP calls, all bought aggressively ABOVE the ask price:

Option Charts:

• $195 Call
• $220 Call

Why This Is Remarkable 💡

Let's put these numbers in plain English:

• $80 million total premium across 114,000 contracts in 25 minutes. That is not a retail trader.
• Z-Score of 115.97 on the first trade means this contract saw volume roughly 115x its historical average. Anything above 3.0 is unusual. Above 10 is very unusual. Above 100 is in the stratosphere.
• All bought ABOVE the ask price. This means the buyer was so eager to get filled that they paid more than the posted asking price -- a hallmark of urgency and conviction. Market makers don't do this. This is a directional bet.
• All classified as BTO (Buy to Open). These are brand-new positions, not someone closing out an existing trade.
• Vol/OI ratio of 3.23x on the $195 strike -- volume was more than triple the entire existing open interest. The buyer single-handedly dwarfed every previous position in this contract.
• 10 months to expiration. This is not a short-term gamble on a single event. Someone is positioning for NVDA to move materially higher by January 2027.

Strike Analysis

• $195 Strike: 8.7% above current price ($179.42). This needs NVDA above ~$222 ($195 + $26.63 premium) to break even -- a 23.7% move. But with 10 months of runway and GTC next week, this is a high-conviction directional play.
• $220 Strike: 22.6% above current price. Breakeven at ~$238 ($220 + $18.21) -- a 32.6% move. Even more aggressive, but if you believe in the AI capex supercycle, $238 is below the analyst consensus target of $260-$274.

---

Technical Analysis 📈

Price Action & Trend

NVDA is trading at $179.42, down roughly 16% from its 52-week high of $212.19 and about 5% off its start-of-year levels. The stock sold off after a beat-and-raise Q4 earnings report on February 25 -- investors fixated on the Q1 gross margin guide of ~71%, down from 75.2% -- and took another hit on March 5 export control headlines.

Current technical signals are mixed: daily moving averages lean bearish (3 Buy / 9 Sell), RSI sits around 55 (neutral territory), and MACD is in positive territory. The stock is consolidating in a horizontal range between roughly $157.50 and $195.30. This pullback-to-consolidation pattern is exactly the type of setup where institutional money starts building long-term positions -- and that appears to be what happened today.

Gamma Levels (Support & Resistance) 🎯

Options market maker positioning tells us where the "gravity" sits in the market. Here's what the gamma exposure (GEX) data shows:

Key Support Levels 📉

Key Resistance Levels 📈

Net GEX Bias: Bullish -- Total call GEX (1,154.7B) exceeds total put GEX (876.9B), indicating positive dealer gamma. When dealers are long gamma, they buy dips and sell rips, which tends to dampen volatility and support orderly price action.

Translation for Normal Humans: NVDA is sitting just below a massive resistance wall at $180. If it pushes through -- and GTC next week could be the catalyst -- the next stops are $185, $190, and the psychologically important $195 level (which happens to be the strike on the biggest trade today). Strong support at $175 means any pullback should find buyers there. The net bullish gamma bias suggests the floor is relatively firm.

Implied Move Data 📊

The options market is pricing in the following ranges:

The January 2027 implied move range of $131.46 to $228.34 is key context for today's trades. The $195 strike sits comfortably within the upper half of this range, and the $220 strike is near the top. The buyer is essentially betting that NVDA reaches or exceeds the upper end of the market's implied distribution -- a bet on a right-tail outcome.

Also note: Triple Witch OPEX falls on March 20 -- the same week as GTC 2026. The combination of massive options expiration and a major product announcement could amplify volatility significantly.

---

Catalyst Calendar 🗓️

Upcoming Catalysts (Next 6 Months) 🚀

1. GTC 2026 Conference -- March 16-19, 2026 (7 DAYS AWAY) This is the most important near-term catalyst. Jensen Huang's keynote on March 16 at 2:00 PM ET is expected to feature:

• Feynman Architecture reveal: NVIDIA's next-gen GPU on TSMC A16 (1.6nm) process with silicon photonics -- potentially the world's first 1.6nm chips shown publicly
• Rubin product roadmap updates: NVL72/NVL144 configurations and customer availability for H2 2026
• New PC CPU chip and Jensen has promised to unveil "several new chips the world has never seen before"
• 1,000+ sessions, 30,000+ attendees expected
• Impact: HIGH -- GTC has historically been a major stock catalyst

2. Q1 FY2027 Earnings -- Expected May 20-27, 2026

• Revenue guided to $78.0 billion (above $73B consensus)
• Consensus EPS: $1.77
• Key watch: gross margin trajectory, Rubin order book commentary, China revenue clarity
• Full-year FY2027 consensus: $316B revenue, $7.46 EPS
• Impact: HIGH

3. Vera Rubin Product Shipments -- H2 2026

• Partner products available from AWS, Google Cloud, Microsoft, OCI, CoreWeave
• Rubin GPU on TSMC 3nm with HBM4 memory: 50 petaflops FP4 vs. 20 for Blackwell
• Revenue contribution begins Q3/Q4 FY2027
• Impact: HIGH

4. Hyperscaler Capex Supercycle

• Big Five projected to spend $600+ billion on infrastructure in 2026, up 36% from 2025
• ~75% directed at AI infrastructure; NVIDIA captures ~90% of AI accelerator spend
• Impact: HIGH (ongoing tailwind)

5. OpenAI & Anthropic IPOs -- Expected H2 2026

• NVIDIA holds $30B OpenAI and $10B Anthropic investments
• Jensen Huang has indicated these are the last major AI company investments
• Impact: MEDIUM

6. China Market Resolution -- Timeline Uncertain

• H200 chip sales approved with 25% tariff but no confirmed shipments yet
• Potential $5-10B+ in incremental annual revenue if resolved
• Currently excluded from company guidance
• Impact: MEDIUM (upside surprise potential)

Recent Catalysts (Already Priced In) ✅

• Q4 FY2026 Earnings Beat (Feb 25): $68.1B revenue, $1.62 EPS -- beat across the board, but stock sold off on margin guide
• $4B Optics Investment (Mar 2): $2B Lumentum + $2B Coherent for co-packaged optics technology
• Meta Partnership (Feb 17): Multiyear, multigenerational deal for millions of Blackwell and Rubin GPUs
• Anthropic $10B Investment: Strategic partnership with Microsoft-NVIDIA-Anthropic triangle
• Vera Rubin Platform Launch (CES, Jan 6-9): Six new chips, up to 10x reduction in inference cost vs. Blackwell
• Export Control Headlines (Mar 5): New restrictions on 40+ nations added pressure

---

Price Targets 🎯

Combining gamma levels, implied move data, analyst targets, and the positioning of today's trades:

Bull Case 🚀 (25% probability)

Target: $230-$260 by January 2027

• GTC 2026 delivers a Feynman blowout that re-rates the stock
• Q1 earnings beat with gross margin recovery guidance
• Vera Rubin ships on schedule in H2, customers rave about performance
• China sales resume, adding $5B+ incremental revenue
• Reaches or exceeds analyst consensus target of $260-$274
• Today's $220 strike trade would be deep in the money

Base Case 📊 (50% probability)

Target: $195-$220 by January 2027

• GTC meets expectations with solid Rubin/Feynman updates
• Revenue growth continues at ~45-50% pace
• Gross margins recover toward mid-70s by H2
• Stock reclaims ground lost since February, pushes past $200
• Gamma resistance at $195-$200 gradually gives way
• Today's $195 strike trade reaches profitability; $220 strike near breakeven

Bear Case 🐻 (25% probability)

Target: $140-$170 by January 2027

• Gross margin compression worsens as Rubin transition costs mount
• Custom ASICs from Google/Amazon/Microsoft meaningfully take share
• Hyperscaler capex cycle shows signs of slowing in H2 2026
• Export controls tighten further, eliminating China upside
• Stock tests lower support at $160-$165
• Today's trades lose significant value

---

Trading Ideas 💰

Conservative Play 🛡️

Bull Put Spread targeting the $175 gamma support floor

• Sell April 17 $175 Put
• Buy April 17 $165 Put
• Rationale: $175 is the strongest gamma support level (108B GEX). You're selling premium with a structural floor beneath you. The April expiry captures GTC as a potential upside catalyst, and the $165 long put defines your risk.
• Max Gain: Net credit received
• Max Loss: $1,000 per spread minus credit received
• Sweet Spot: NVDA stays above $175 through April OPEX

Balanced Play ⚖️

Call Debit Spread matching the institutional thesis

• Buy June 19 $185 Call
• Sell June 19 $200 Call
• Rationale: Aligns with the institutional direction (bullish LEAPS) but uses a shorter timeframe and defined risk. The $185 entry is just above the current $180 resistance -- if GTC breaks the stock through that wall, this spread benefits from both delta and gamma expansion. The June quarterly expiry gives 3+ months of runway covering both GTC and Q1 earnings.
• Max Gain: $1,500 per spread
• Max Loss: Net debit paid
• Breakeven: $185 + net debit

Aggressive Play 🔥

Follow the whale into January 2027 LEAPS (smaller size)

• Buy January 2027 $195 Call (NVDA20270115C195)
• Current Price: ~$26.63 per contract ($2,663 per contract)
• Rationale: This is literally the same trade the institutional buyer made today. The $195 strike is at the top of the current gamma range and right at a key technical resistance level. With 10 months of runway, this captures GTC, Q1 and Q2 earnings, Vera Rubin shipments, and potential China resolution. The trade needs NVDA above $221.63 to break even, which is below the average analyst target.
• Risk: Entire premium ($2,663 per contract). Size this small -- 1-2% of your portfolio max.
• Why it works: You have the same expiration and strike as someone who was willing to pay $38 million for this position. Their research budget is probably bigger than yours.

---

Risk Factors ⚠️

Position Sizing Guidelines

• Conservative: 1-2% of portfolio per trade
• Balanced: 2-3% of portfolio per trade
• Aggressive: No more than 3-5% on a single LEAP position

Key Risks to Watch

1. Gross Margin Compression: The Q1 guide of ~71% is a real concern. Architecture transitions always squeeze margins, and recovery to mid-70s is not guaranteed. If margins disappoint further, the multiple compresses and the stock revisits lower levels regardless of revenue growth.

2. Custom ASIC Acceleration: Custom chip shipments are projected to grow 44.6% in 2026 vs. 16.1% for GPUs. Google already handles 75%+ of Gemini computations on its own TPUs. NVIDIA's biggest customers are also its biggest competitive threats.

3. Export Controls: The situation remains fluid. New restrictions on 40+ nations were announced March 5, and China sales remain stalled despite H200 approvals. Any tightening could remove upside optionality.

4. Customer Concentration: 40-50% of revenue comes from just four customers (Microsoft, Meta, Amazon, Alphabet). If any single hyperscaler pulls back capex, the impact is disproportionate.

5. OpenAI Deal Shrinkage: The original $100B deal collapsed to $30B amid friction over GPU inference performance. If OpenAI's complaints about hardware performance are shared by other large customers, that is a signal worth watching.

6. Insider Selling: 188 insider transactions in the last 90 days -- all sales, totaling $3.55 billion. This is common at companies this size, but it is not a bullish signal.

7. GTC Disappointment Risk: The market may be pricing in a spectacular keynote. If Jensen's announcements merely meet expectations, the "sell the news" dynamic could push the stock lower.

Stop Loss Suggestions

• Stock Position: Close below $170 (breaks the $175 gamma support and 200-day zone)
• Options: Cut losses at 40-50% of premium on directional trades
• Spreads: Manage at 1.5-2x max loss if the spread moves against you early

---

The Bottom Line 📝

Someone just spent $80 million across three trades betting NVDA goes meaningfully higher over the next 10 months. All three were bought ABOVE the ask -- the options market equivalent of walking into a car dealership and paying over sticker price because you want the car that badly. The first trade alone carried a z-score of 115.97, meaning it was 115x the normal volume for that contract. These are not random trades. This is institutional capital deploying with conviction.

The timing is not a coincidence. GTC 2026 starts in 7 days (March 16-19), and Jensen Huang has been publicly teasing "several new chips the world has never seen before." The buyer is positioning ahead of what could be a major re-rating catalyst -- and they chose 10-month LEAPS rather than short-dated options, suggesting they see this as the beginning of a move, not a one-week trade.

✅ Bullish Factors:

• $80M institutional LEAP buying with extreme urgency (ABOVE ASK)
• GTC 2026 imminent with potentially transformative announcements (Feynman on 1.6nm)
• Q1 revenue guided to $78B, $5B above consensus
• $600B+ hyperscaler capex cycle still accelerating
• Valuation reasonable at ~26x forward earnings with 48%+ revenue growth
• Net bullish gamma bias with strong support at $175

⚠️ Concerns:

• Sitting at $180 resistance wall (284B GEX)
• Gross margin compression (71% guide vs. 75.2% in Q4)
• Custom ASIC competition growing faster than GPU shipments
• Export control overhang unresolved
• Heavy insider selling ($3.55B in 90 days)

Our Read: The institutional positioning here is extremely compelling. An $80 million bet with a 115x z-score, timed just before the year's most important product event, in a stock trading 16% below its highs with a sub-30x forward P/E -- that is a setup worth paying attention to. The key question is whether GTC delivers a Feynman "wow moment" that breaks the stock through $180 resistance and triggers a re-rating toward the $200+ levels where this trade starts paying off.

For short-term traders, watch the $180 level closely during GTC week. A clean break with volume opens the door to $190-$195 quickly. For longer-term options traders, the January 2027 LEAPS give you time to be right -- and time is exactly what you need when you are buying a stock in a temporary pullback within a secular growth trend.

---

Analysis Date: March 9, 2026 Current Price: ~$179.42 Data Sources: Options flow data, GEX analytics, implied volatility surface, company filings, analyst reports

Disclaimer: This analysis is for educational and informational purposes only and does not constitute investment advice. Options trading involves substantial risk of loss and is not suitable for all investors. The unusual options activity described here reflects observed market data and does not guarantee future price movement. Past performance does not guarantee future results. Always conduct your own due diligence and consult with a qualified financial advisor before making investment decisions. Never risk more than you can afford to lose.